Amedisys, Inc.
AMED
$100.99
$0.0050.01%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 4.55% | -0.55% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 4.55% | -0.55% | |||
| Cost of Revenue | 4.32% | -3.07% | |||
| Gross Profit | 4.86% | 2.88% | |||
| SG&A Expenses | 0.06% | -3.23% | |||
| Depreciation & Amortization | -1.69% | -2.61% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 2.71% | -3.12% | |||
| Operating Income | 20.97% | 30.24% | |||
| Income Before Tax | -47.01% | 574.33% | |||
| Income Tax Expenses | -34.41% | 367.08% | |||
| Earnings from Continuing Operations | -53.01% | 342.25% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -19.65% | -115.75% | |||
| Net Income | -53.97% | 399.36% | |||
| EBIT | 20.97% | 30.24% | |||
| EBITDA | 18.72% | 26.55% | |||
| EPS Basic | -54.05% | 398.97% | |||
| Normalized Basic EPS | 25.99% | 6.80% | |||
| EPS Diluted | -54.35% | 394.92% | |||
| Normalized Diluted EPS | 25.94% | 5.43% | |||
| Average Basic Shares Outstanding | 0.17% | 0.13% | |||
| Average Diluted Shares Outstanding | 0.21% | 1.43% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||